The SIBERIA Trial (Acculink™ Versus CGuard™) — CAS  

Asymptomatic Patients (Stenosis =80%) Clinical Trial

Official title: Independent Randomized Trial in Carotid Artery Revascularization Comparing the Stent (Acculink™) Versus the Mesh Covered Stent (CGuard™) The SIBERIA Trial

Status Completed

Clinical Trial Summary

That the study will be carried out as it has the protocol instructions, respecting the applicable regulations for clinical investigations with medical devices and following the internationally accepted ethical standards

Clinical Trial Description

Independent Randomized Trial in Carotid Artery Revascularization Comparing the Stent (Acculink™) Versus the Mesh Covered Stent (CGuard™) was performed. Ischemic lesions of brain after CAS were determined by MRI before and after treatment (2-3 days, 1 month). ;

Related Conditions & MeSH terms

• Asymptomatic Patients (Stenosis =80%)
• Carotid Stenosis
• Constriction, Pathologic
• Patients With Aterosclerotic Carotid Stenosis
• Symptomatic Patients (Stenosis > 50%)

• NCT number: NCT03488199
• Study type: Interventional
• Source: Meshalkin Research Institute of Pathology of Circulation
• Status: Completed
• Phase: N/A
• Start date: September 11, 2017
• Completion date: March 9, 2021